Keyphrases
Human Skin
100%
Low-dose Aspirin
100%
Skin Blood Flow
100%
Cutaneous Vasodilation
63%
Platelets
54%
Reflex
45%
Cyclooxygenase-1 (COX-1)
36%
Vasodilation
36%
Platelet Aggregation Inhibitors
27%
Published Data
18%
Middle-aged
18%
Clopidogrel
18%
Functional Consequences
18%
Aspirin
18%
Platelet Inhibition
18%
Heat Stress
18%
Secondary Prevention
18%
Chronic Low Dose
18%
Primary Prevention
18%
Whole Blood
18%
Blood Viscoelasticity
9%
Aggregating Agents
9%
Local Heating
9%
Functional Impact
9%
Vasodilator
9%
Viscoelastic Properties
9%
Cardiovascular Risk
9%
During Exercise
9%
Public Health
9%
Irreversible Inhibitor
9%
Core Body Temperature
9%
Signaling Mechanism
9%
Iontophoresis
9%
Effector Mechanisms
9%
Platelet Production
9%
Aged Persons
9%
Shear Stress
9%
Antiplatelet Therapy
9%
Academy
9%
Thromboxane A2 (TXA2)
9%
Stress Mechanism
9%
Older People
9%
Vasodilatory
9%
Potential Functional
9%
Exercise in the Heat
9%
Adrenergic Regulation
9%
Microvasculature
9%
Over 45
9%
Reactive Hyperemia
9%
Neuroscience
Aspirin
100%
Vasodilation
84%
Antiplatelet Drug
23%
Clopidogrel
15%
Cyclooxygenase 1
15%
Cyclooxygenase
15%
Signaling Mechanism
7%
Adenosine Diphosphate
7%
Iontophoresis
7%
Thromboxane A2
7%
Bretylium
7%
Vasoconstrictors
7%
Microvessel
7%
Pharmacology, Toxicology and Pharmaceutical Science
Acetylsalicylic Acid
100%
Antithrombocytic Agent
23%
Prostaglandin Synthase
15%
Diseases
15%
Cyclooxygenase 1
15%
Clopidogrel
15%
Bretylium
7%
Adenosine Diphosphate
7%
Thromboxane A2
7%
Iontophoresis
7%
Antiplatelet
7%
Receptor
7%
Hyperaemia
7%